In this second edition of Primer on Multiple Sclerosis, the latest updates on therapeutics will be provided, including new medications that have been FDA- approved since the first edition.
Informations bibliographiques
mars 2016, Anglais
Oxford Academic
978-0-19-934101-6
Sommaire
Mots-clés
Contenu
In this second edition of Primer on Multiple Sclerosis, the latest updates on therapeutics will be provided, including new medications that have been FDA- approved since the first edition.